Vir Biotechnology
512 employees
Biotech/Pharma
Public · $908.6M
Open positions (12)
Company details
Team Size512
IndustryBiotech/Pharma
Funding
Total raised
$908.6M
Last stage
Public
Investors
SoftBank Vision Fund
Total raised
$908.6M
Last stage
Public
Investors
Robert Nelsen
Managing Director at ARCH Venture Partners; co-founded Vir Biotechnology and led the firm's $150M seed investment alongside the Bill & Melinda Gates Foundation.
Klaus Frueh
Listed as co-founder of Vir Biotechnology by Tracxn; scientific co-founder of the company.
George Scangos
Former CEO of Biogen, recruited as founding CEO of Vir Biotechnology at launch in 2017; led the company through its IPO in 2019 and retired in April 2023.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.